Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

RECURSION PHARMACEUTICALS, INC.

RXRX · Nasdaq · CIK 0001601830 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

41 Form 4 transaction lines observed in the same window
15 sales · 26 option, withholding, award, gift or other lines

Last qualifying purchase2023-03-02 · Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC · $522.5K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Gibson ChristopherDirector
○▼○○▼○○▼○▼
Borgeson BlakeDirector
▼▼○▼▼▼▼
Taylor Ben RChief Financial Officer
○○○○
Khan NajatCEO and President
○▼○▼
Bumpus NamandjeDirector
▼○▼
Li Dean YDirector
○○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-03-02 · Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC.

Recent Form 4 activity

0Purchases
36Sales
69Other Form 4 lines
71SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING15 sale line(s) · context only
OTHER26 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
157,938,412
Previous report
178,724,433
Avg daily volume
25,774,840
Days to cover
6.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2023-03-02Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock66,822USD 7.82USD 522,548SEC filing ↗
2023-03-01Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock48,867USD 7.94USD 388,004SEC filing ↗
2023-02-28Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock815USD 7.97USD 6,496SEC filing ↗
2023-02-27Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock52,500USD 7.69USD 403,725SEC filing ↗
2023-02-24Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock109,118USD 7.64USD 833,662SEC filing ↗
2023-02-23Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock51,864USD 7.79USD 404,021SEC filing ↗
2023-02-22Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock50,941USD 7.83USD 398,868SEC filing ↗
2023-02-21Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock94,418USD 7.74USD 730,795SEC filing ↗
2023-02-17Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock63,382USD 7.71USD 488,675SEC filing ↗
2023-02-16Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock42,682USD 7.90USD 337,188SEC filing ↗
2023-02-14Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock6,300USD 7.95USD 50,085SEC filing ↗
2023-02-13Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock32,474USD 7.97USD 258,818SEC filing ↗
2023-02-10Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock11,000USD 7.98USD 87,780SEC filing ↗
2023-02-01Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock600USD 7.97USD 4,782SEC filing ↗
2023-01-26Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSCPurchase (P)Class A Common Stock7,886USD 7.99USD 63,009SEC filing ↗

Form 4 evidence

105 transaction lines in the latest 365-day window; 1,125 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-06HERSHBERG ROBERTSale (S)Class A Common Stock25,000USD 5.00USD 125,000SEC filing ↗
2026-10-06HERSHBERG ROBERTOption exercise / conversion (M)Class A Common Stock25,000USD 2.22USD 55,500SEC filing ↗
2026-10-06Borgeson BlakeSale (S)Class A Common Stock50,000USD 4.84USD 242,000SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-06HERSHBERG ROBERTSale (S)Class A Common Stock25,000USD 5.00USD 125,000SEC filing ↗
2026-10-06HERSHBERG ROBERTOption exercise / conversion (M)Class A Common Stock25,000USD 2.22USD 55,500SEC filing ↗
2026-10-06Borgeson BlakeSale (S)Class A Common Stock50,000USD 4.84USD 242,000SEC filing ↗
2026-10-01Li Dean YAward / grant (A)Class A Common Stock3,378USD 0.00USD 0SEC filing ↗
2026-10-01Dar ZavainAward / grant (A)Class A Common Stock4,607USD 0.00USD 0SEC filing ↗
2026-09-15Taylor Ben RTax withholding (F)Class A Common Stock5,396USD 3.41USD 18,400SEC filing ↗
2026-09-08Khan NajatSale (S)Class A Common Stock22,408USD 3.52USD 78,876SEC filing ↗
2026-09-01Borgeson BlakeSale (S)Class A Common Stock30,000USD 3.34USD 100,200SEC filing ↗
2026-08-17Taylor Ben RTax withholding (F)Class A Common Stock25,018USD 3.16USD 79,057SEC filing ↗
2026-08-17Khan NajatTax withholding (F)Class A Common Stock80,498USD 3.16USD 254,374SEC filing ↗
2026-08-17Hallett DavidTax withholding (F)Class A Common Stock26,657USD 3.16USD 84,236SEC filing ↗
2026-08-04Borgeson BlakeSale (S)Class A Common Stock30,000USD 3.25USD 97,500SEC filing ↗
2026-07-07Borgeson BlakeSale (S)Class A Common Stock40,000USD 3.96USD 158,400SEC filing ↗
2026-07-01Li Dean YAward / grant (A)Class A Common Stock3,747USD 0.00USD 0SEC filing ↗
2026-07-01Dar ZavainAward / grant (A)Class A Common Stock5,109USD 0.00USD 0SEC filing ↗
2026-06-18Bumpus NamandjeSale (S)Class A Common Stock3,963USD 3.18USD 12,602SEC filing ↗
2026-06-17Sun Elaine DAward / grant (A)Class A Common Stock88,424USD 0.00USD 0SEC filing ↗
2026-06-17Michor FranziskaAward / grant (A)Class A Common Stock88,424USD 0.00USD 0SEC filing ↗
2026-06-17Li Dean YAward / grant (A)Class A Common Stock88,424USD 0.00USD 0SEC filing ↗
2026-06-17HERSHBERG ROBERTAward / grant (A)Class A Common Stock88,424USD 0.00USD 0SEC filing ↗
2026-06-17Dar ZavainAward / grant (A)Class A Common Stock88,424USD 0.00USD 0SEC filing ↗
2026-06-17Bumpus NamandjeAward / grant (A)Class A Common Stock88,424USD 0.00USD 0SEC filing ↗
2026-06-17Borgeson BlakeAward / grant (A)Class A Common Stock88,424USD 0.00USD 0SEC filing ↗
2026-06-15Taylor Ben RTax withholding (F)Class A Common Stock5,396USD 3.15USD 16,997SEC filing ↗
2026-06-05Khan NajatSale (S)Class A Common Stock23,588USD 3.58USD 84,445SEC filing ↗
2026-06-05Gibson ChristopherSale (S)Class A Common Stock40,000USD 3.62USD 144,800SEC filing ↗
2026-06-05Gibson ChristopherC (C)Class A Common Stock40,000USD 0.00USD 0SEC filing ↗
2026-06-03Bumpus NamandjeSale (S)Class A Common Stock4,386USD 3.54USD 15,526SEC filing ↗
2026-06-02Borgeson BlakeSale (S)Class A Common Stock30,000USD 3.68USD 110,400SEC filing ↗
2026-05-22Gibson ChristopherSale (S)Class A Common Stock40,000USD 3.08USD 123,200SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerRXRX
CIK0001601830
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history1,125 transaction lines from 2021-04-16 to 2026-10-06
29 P purchase lines · 410 S sale lines · 686 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.